CIK 0000925741
- Non-accelerated filer
- Smaller reporting company
BioCardia, Inc.
Sign in to watch- Ticker
- BCDA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 232753988
- Phone
- +1 650-226-0123
- Business address
- 320 SOQUEL WAY, SUNNYVALE, CA, 94085
- Former names
- Tiger X Medical, Inc., Cardo Medical, Inc., CLICKNSETTLE COM INC, NAM CORP
- 4 Open-market buy Director bought 5,000 shares at $1.50 ($7,500)
- 4 Open-market buy President and CEO bought 700 shares at an average $1.59 ($1,110)
- 4 Open-market buy President and CEO bought 1,600 shares at an average $1.37 ($2,184)
- 4 Open-market buy President and CEO bought 5,000 shares at $1.33 ($6,650)
- 4 Open-market buy President and CEO bought 1,500 shares at $1.46 ($2,190)
- 4 Open-market buy President and CEO bought 3,000 shares at $1.45 ($4,350)
- 4 Open-market buy President and CEO bought 1,000 shares at $1.45 ($1,450)
- 4 Open-market buy Director bought 18,000 shares at an average $1.89 ($33,960)
- 4 Open-market buy Chief Financial Officer bought 500 shares at $1.90 ($950)
- 4 Open-market buy Director bought 7,000 shares at an average $1.89 ($13,250)
- 4 Open-market buy Chief Financial Officer bought 750 shares at $1.90 ($1,425)
- 4 Open-market buy President and CEO bought 5,000 shares at $2.03 ($10,150)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Exercise or conversion Vice President of Quality acquired 807,591 shares (option exercise)
- 4 Exercise or conversion Vice President of Quality acquired 823,125 shares (option exercise)
- 4 Derivatives Options or other derivatives
Page 16 of 23 · 442 filings